Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring [NA]

View source ↗

Summary

A clinical trial investigating therapeutic pharmacological monitoring to optimize hydroxyurea treatment for sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Sickle Cell Disease | NA | Status: RECRUITING